Associations between serum lipoprotein(a) levels and the severities of aortic and coronary atherosclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Associations between serum lipoprotein(a) levels and the severities of aortic and coronary atherosclerosis ; volume:12 ; number:1 ; day:21 ; month:1 ; year:2010 ; pages:1-2 ; date:1.2010
Journal of cardiovascular magnetic resonance ; 12, Heft 1 (21.1.2010), 1-2, 1.2010
- Urheber
-
Momiyama, Yukihiko
- Beteiligte Personen und Organisationen
-
Ohmori, Reiko
Fayad, Zahi A.
Kihara, Teruyoshi
Kato, Ryuichi
Taniguchi, Hiroaki
Nagata, Masayoshi
Nakamura, Haruo
Ohsuzu, Fumitaka
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-12-S1-P131
- URN
-
urn:nbn:de:1111-201603223351
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Momiyama, Yukihiko
- Ohmori, Reiko
- Fayad, Zahi A.
- Kihara, Teruyoshi
- Kato, Ryuichi
- Taniguchi, Hiroaki
- Nagata, Masayoshi
- Nakamura, Haruo
- Ohsuzu, Fumitaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lipoprotein(a)
The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Lipoprotein(a) in nephrological patients
Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Lipoprotein(a): from Causality to Treatment
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention
Lipoprotein(a)
The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Lipoprotein(a) in nephrological patients
Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Lipoprotein(a): from Causality to Treatment
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention
Lipoprotein(a)
The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Lipoprotein(a) in nephrological patients
Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Lipoprotein(a): from Causality to Treatment
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention